Filing Flows › Comparisons › ALMR vs QTRX
Alamar Biosciences vs Quanterix: ALMR and QTRX compared
Alamar Biosciences is the larger company: $33.5M of revenue in its latest quarter (Q3 2026) against $32.9M for Quanterix (Q2 2026). Alamar Biosciences is growing faster (+68% against +34% a year earlier). Alamar Biosciences is more profitable, with an operating margin of -45.1% against -150.2%.
Where the money goes: ALMR and QTRX
Alamar Biosciences (ALMR) · Q3 2026
Alamar Biosciences, Q3 2026: revenue $33.5M (+68% year over year), operating margin -45.1%, net loss $13.3M, operating cash flow −$14.7M. The chart follows the revenue to costs, profit and cash.
Quanterix (QTRX) · Q2 2026
Quanterix, Q2 2026: revenue $32.9M (+34% year over year), operating margin -150.2%, net loss $48.9M, operating cash flow −$5.1M. The chart follows the revenue to costs, profit and cash.
| Alamar Biosciences (ALMR) | Quanterix (QTRX) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q2 2026 |
| Revenue | $33.5M | $32.9M |
| Revenue growth, Y/Y | +68% | +34% |
| Operating margin | -45.1% | -150.2% |
| Net earnings | −$13.3M | −$48.9M |
| Net margin | -39.8% | -148.7% |
| Operating cash flow | −$14.7M | −$5.1M |
| Market value | — | $147M |
| Analysts’ mean target | — | $3.17 |
Where the revenue comes from
Alamar Biosciences
- Product: $26.3M (78%)
- Service Other: $7.2M (22%)
Quanterix
- Product revenue: $23.4M (71%)
- Spatial biology: $9.3M (28%)
Questions
Which is bigger, Alamar Biosciences or Quanterix?
Alamar Biosciences is the larger company: $33.5M of revenue in its latest quarter (Q3 2026) against $32.9M for Quanterix (Q2 2026).
Is Alamar Biosciences or Quanterix growing faster?
Alamar Biosciences is growing faster (+68% against +34% a year earlier).
Which is more profitable, Alamar Biosciences or Quanterix?
Alamar Biosciences is more profitable, with an operating margin of -45.1% against -150.2%.
More: Alamar Biosciences earnings · how Alamar Biosciences makes money · Quanterix earnings · how Quanterix makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 4, 2026; 10-Q filed Aug 10, 2026). Fiscal quarters can end on different dates. Not investment advice.